Recce Pharmaceuticals Expands Market Presence

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.

Recce Pharmaceuticals Ltd. has announced a new application for the quotation of securities, specifically 9,844,296 ordinary shares, on the ASX under the code RCE, with an issue date of August 6, 2024. This move indicates a potential expansion of Recce Pharmaceuticals’ financial footprint and an opportunity for investors to engage with the company’s growth.

For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.